CJC-1295 & Ipamorelin Blend (10mg)

$80.00

CJC-1295 & IPAMORELIN BLEND

Ipamorelin appears to work by increasing the basal expression of GH. CJC-129 may then act upon the higher basal levels of GH to potentially improve the threshold for both high and low GH levels while maintaining the hormone expression cycle. CJC-129 & Ipamorelin blend may positively influence the body by improving lean body mass, better utilization of insulin, superior muscle development, and overall improved metabolic capabilities. This is suggested by the positive nitrogen balance reported in some studies. In one study, researchers aimed to examine the metabolic potential of Ipamorelin on specific hepatic indicators of alpha-amino-nitrogen conversion during catabolism induced by steroids. The researchers assessed the hepatic capacity for synthesizing urea-N (CUNS), which is a potential indicator of nitrogen metabolism in the liver. They measured the apparent levels of messenger RNA (mRNA) associated with urea cycle enzymes in the liver, evaluated the overall nitrogen balance, and hypothesized the nitrogen contents of various organs. It is suggested that Ipamorelin possibly resulted in a 20% reduction in CUNS when compared to the catabolic state induced by steroids. Additionally, it may have potentially lowered the expression of urea cycle enzymes, restored nitrogen balance, and hypothetically normalized or improved the nitrogen contents in organs.[11] Finally, since these peptides appear to have slightly different pharmacokinetics, their combinational action may have strong impacts. CJC-129 (when with DAC) appears to possess a longer half-life of about 6-8 days, which would mean a sustained increase in growth hormone levels. Having an apparent shorter half-life, Ipamorelin is likely to produce quick action and be cleared rapidly from the blood. Therefore, the two peptides may be used to provide a rapid onset of action with Ipamorelin and prolonged effects with CJC-129.

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only

 

Category:
Wishlist Compare

CJC-1295 & Ipamorelin Blend 10mg – Your Ultimate GH Boost

Tired of slow gains and endless fatigue? Our CJC-1295 & Ipamorelin Blend 10mg is the perfect synergy for men and women over 30 who want youthful growth hormone levels naturally.

Unlike single peptides, this premium blend delivers both extended and pulsed GH release—resulting in deeper sleep, faster fat loss, lean muscle growth, and glowing skin within weeks.

Because it mimics your body’s natural rhythm, you get dramatic results without water retention or “HGH gut.”

Just one simple bedtime injection unlocks 3–5x higher GH levels. 99.9% pure, USA-made, lab-tested.

Ready to feel 10 years younger? Grab your vial today and transform your body in 2025

ing to 3–5x higher growth hormone levels compared to either peptide alone.

Because the blend stimulates your pituitary naturally, results look completely organic – no bloated “HGH gut” or water retention.- Easy reconstitution with bacteriostatic water
– 10mg total blend (5mg CJC-1295 + 5mg Ipamorelin) per vial

Perfect for anti-aging clinics, biohackers, fitness enthusiasts, and anyone over 30 wanting to reclaim their biological prime.

Simple Dosing, Maximum Results
Just 200–300mcg injected subcutaneously before bed, 5–7 nights per week. Many customers stack with BPC-157 or GHK-Cu for even faster recovery and skin rejuvenation.

Ready to turn back the clock? Add CJC-1295 & Ipamorelin Blend 10mg to your cart today and experience the gold standard in growth hormone optimization. Limited stock – ships discreetly within 24 hours.

 

 

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 & Ipamorelin Blend (10mg)”

Your email address will not be published. Required fields are marked *